Guru Anand Medical And Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-11-2024
- Paid Up Capital ₹ 50.00 K
as on 03-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 55.26%
(FY 2023)
- Profit -542.59%
(FY 2023)
- Ebitda -382.93%
(FY 2023)
- Net Worth 1879.33%
(FY 2023)
- Total Assets 425.60%
(FY 2023)
About Guru Anand Medical And Research Foundation
The Corporate was formerly known as Gautamalaya Foundation. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Satish Surana and Subhash Mutha serve as directors at the Company.
- CIN/LLPIN
U85300PN2021NPL197620
- Company No.
197620
- Company Classification
Private Not For Profit Company
- Incorporation Date
12 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Guru Anand Medical And Research Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Surana  | Director | 12-Jan-2021 | Current |
| Subhash Mutha | Director | 12-Jan-2021 | Current |
Financial Performance of Guru Anand Medical And Research Foundation.
Guru Anand Medical And Research Foundation, for the financial year ended 2023, experienced significant growth in revenue, with a 55.26% increase. The company also saw a substantial fall in profitability, with a 542.59% decrease in profit. The company's net worth Soared by an impressive increase of 1879.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Guru Anand Medical And Research Foundation?
In 2023, Guru Anand Medical And Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surana Project Financial Consultancy Pvt LtdActive 33 years 5 monthsSatish Surana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Guru Anand Medical And Research Foundation?
Guru Anand Medical And Research Foundation has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Guru Anand Medical And Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Guru Anand Medical And Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
